Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-002394·Solid Biosciences Inc.
Schedule 13G ownership disclosure
Solid Biosciences Inc
Common Stock, par value $0.001 per share · CUSIP: 83422E204
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Vestal Point Capital, LP
Shares: 1,753,558.00 · Class: 2.3%
- Ryan Wilder
Shares: 1,753,558.00 · Class: 2.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-002394
- Form type
- SCHEDULE 13G/A
- Filer
- Solid Biosciences Inc.
- CIK
- CIK 1707502
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership